Creating EU-CTR compliant and patient-friendly lay language summaries (LLS)

Return to Insights Center

Related Insights

Playbook

Streamlining success: How integrated evidence planning transforms asset development

Feb 27, 2025

Blog

Breaking through complex regulations and science speak – thinking “patients first” in lay language summary development

Jun 22, 2021

Blog

Regulatory outsourcing: Applying change management best practices for smoother transitions

Jul 24, 2025

Whitepaper

Optimizing the Route to Regulatory Approval for a Novel Vaccine

Aug 18, 2023

Webinar

How to navigate China’s regulatory environment

Feb 15, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Blog

Population variability: important considerations in vaccine development

Jun 14, 2023

Related Insights

Playbook

Streamlining success: How integrated evidence planning transforms asset development

Feb 27, 2025

Blog

Breaking through complex regulations and science speak – thinking “patients first” in lay language summary development

Jun 22, 2021

Blog

Regulatory outsourcing: Applying change management best practices for smoother transitions

Jul 24, 2025

Whitepaper

Optimizing the Route to Regulatory Approval for a Novel Vaccine

Aug 18, 2023

Webinar

How to navigate China’s regulatory environment

Feb 15, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Show more